查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
美國兒科心臟病市場規模和預測、國家佔有率、趨勢和成長機會分析報告範圍：按產品類型、手術程序、最終用戶、疾病適應症和國家/地區
市場調查報告書
商品編碼
1591399

美國兒科心臟病市場規模和預測、國家佔有率、趨勢和成長機會分析報告範圍：按產品類型、手術程序、最終用戶、疾病適應症和國家/地區

US Pediatric Cardiology Market Size and Forecast, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Surgical Procedures, End User, Disease Indication, and Country
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 訂單完成後即時交付

價格

美國兒科心臟病市場規模預計將從 2023 年的 25.4 億美元增至 2031 年的 35.9 億美元。

兒科心臟病學是醫學的一個專業分支，專注於診斷、治療和管理嬰兒、兒童和青少年的心臟病。該領域解決一系列先天性（出生時存在）和後天性心臟缺陷，包括室間隔缺損、房間隔缺損以及需要手術干預的更複雜的問題。

公司的策略舉措

在美國兒科心臟病市場營運的公司不斷關注產品批准、合作、融資、協議和新產品發布等策略發展，這有助於他們提高銷售額、地理覆蓋範圍和滿足廣泛客戶群的能力。以下提到了美國兒科心臟病學市場主要參與者採取的一些策略性舉措：

2024年1月，Occlutech獲得美國食品藥物管理局（FDA）核准用於治療心房中隔缺損（ASD）的Occlutech Pistol Pusher和Occlutech ASD封堵器。獲得批准後，Occlutech 將立即與經銷商B. Braun Interventional Systems Inc. 獨家合作開始商業化。繖形軟性盤組成中間連接兩個圓盤。

2023 年2 月，美敦力重新推出Harmony 經導管肺動脈瓣(TPV) 系統，這是一種微創心臟直視手術替代方案，適用於患有天然或手術修復右心室流出道(RVOT) 的先天性心臟病患者。該系統是為患有 RVOT 異常的患者設計的，這些患者還患有嚴重的肺動脈瓣逆流，這是一种血液被泵入肺部後滲漏到心臟右下腔的情況。

2022 年 5 月，Occlutech 與 B. Braun Interventional Systems Inc (BIS) 簽署了獨家經銷協議。 BIS 將在全球 Occlutech 團隊的支持下啟動 Occlutech Flex II ASD 封堵器在美國的商業化活動。透過此次合作，Occlutech 在具有重要戰略意義的美國市場取得了成功，該市場的特點是具有首要且具有商業吸引力的醫療保健系統。此外，BIS 透過對先天性和結構性心臟的強烈關注，提高了其投資組合的相關性。

因此，各公司專注於兒科心臟病設備開發的策略舉措可能會在未來幾年為美國兒科心臟病市場提供成長機會。

然而，熟練的兒科心臟病專家的缺乏正在影響患有心血管疾病的兒童的護理的可用性和品質。隨著先天性心臟病和其他心臟病的發病率持續上升，對專業心臟病學服務的需求正在超過訓練有素的專業人員的供應。此外，人們對預防性心臟病護理的認知不斷提高，以解決出生後立即出現的長期兒科心臟病問題。據美國兒科學會稱，兒科心臟病專家明顯短缺，特別是在美國農村和服務不足的地區，這些地區獲得專業護理的機會往往有限。根據美國兒科委員會 (ABP) 截至 2023 年 6 月的資料，已有 4,117 名兒科心臟病專家獲得了委員會認證，其中 3,096 名 (75%) 積極參與了認證維持 (MOC)。當勞動力僅限於美國時，到2023 年，每個州平均有57.3 名經過委員會認證的兒科心臟科醫生（範圍0-329），即每10 萬名17 歲以下兒童（範圍0.0-25.4）就有4 名心臟科醫生。各州內兒科心臟科專家的分佈有很大差異，大多數集中在城市地區，很少在農村地區。兒科心臟科專家的短缺也增加了現有從業人員的壓力，導致倦怠和工作不滿。這種情況最終會影響患者的治療結果，因為過度勞累的專家可能無法為複雜病例提供所需的全面護理。因此，熟練的兒科心臟病專家的缺乏阻礙了市場的成長。

基於最終用戶的見解

根據最終用戶，兒科心臟病市場分為醫院、專科診所等。 2023 年，醫院細分市場佔據主導地位。先天性心臟病和其他心臟病病例的不斷增加，要求兒科心臟中心擁有現代技術和多學科團隊進行綜合治療。波士頓兒童醫院、德州兒童醫院、西雅圖兒童醫院和費城兒童醫院都是公認的領導者，擁有最先進的設施和創新的兒科心臟病學方法，包括微創外科技術和介入手術。這些醫院強調協作護理，心臟科醫生與其他外科醫生、麻醉師和護理人員合作，以確保最佳化治療結果。西雅圖兒童醫院在 2023 年進行了約 570 例兒科心臟手術。健康系統中加強的專業護理和治療方案可確保醫院部門的成長和兒科心臟病學的進步，這將改善患有心血管問題的年輕患者的生活品質。

美國心臟病學會、兒童心臟基金會、疾病管制與預防中心、美國食品藥物管理局、美國兒科學會是準備美國兒科心臟病市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：美國兒科心臟病學市場格局

  • 概述
  • PEST分析
  • 美國胸骨切開術手術分析

第 5 章：美國兒科心臟病市場 - 主要市場動態

  • 美國兒科心臟病市場 - 主要市場動態
  • 市場促進因素
    • 兒科先天性心臟病發生率不斷增加
    • 擴大轉向微創手術
  • 市場限制
    • 缺乏熟練的兒科心臟科專家
  • 市場機會
    • 公司的策略舉措
  • 未來趨勢
    • 人工智慧和機器學習與兒科心臟病學的整合
  • 促進因素和限制的影響：

第 6 章：美國兒科心臟病市場分析

  • 美國兒科心臟病市場收入，2021-2031

第 7 章：美國兒科心臟病市場分析 - 按產品類型

  • 經導管心臟瓣膜
  • 封堵器
  • 斑塊切除裝置
  • 導管
  • 支架
  • 導管鞘
  • 其他

第 8 章：美國兒科心臟病學市場分析 - 按手術程序

  • 介入治療
  • 心律管理程式
  • 其他

第 9 章：美國兒科心臟病學市場分析 - 按最終用戶

  • 醫院
  • 專科診所
  • 其他

第 10 章：美國兒科心臟病學市場分析 - 按疾病適應症

  • 患者卵圓孔 (PFO)
  • 先天性心臟病
  • 後天性心臟病
  • 心律不整
  • 心肌病變
  • 其他

第 11 章：產業格局

  • 概述
  • 美國兒科心臟病市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Abbott Laboratories
  • Medtronic Plc
  • Edwards Lifesciences Corp
  • Terumo Corp
  • W L Gore and Associates Inc
  • NuMED
  • Cordis Corp
  • Occlutech US LLC
  • Biotronik SE & Co KG
  • RENATA MEDICAL

第 13 章：附錄

Product Code: TIPRE00039351

The US pediatric cardiology market size is projected to reach US$ 3.59 billion by 2031 from US$ 2.54 billion in 2023. The market is expected to register a CAGR of 4.4% during 2023-2031.

Pediatric cardiology is a specialized branch of medicine that focuses on diagnosing, treating, and managing heart conditions in infants, children, and adolescents. This field addresses a range of congenital (present at birth) and acquired heart defects, including conditions like ventricular septal defects, atrial septal defects, and more complex issues requiring surgical intervention.

Strategic Initiatives by Companies

Companies operating in the US pediatric cardiology market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them boost their sales, geographic reach, and capacities to cater to a wide customer base. A few strategic initiatives taken by key players operating in the US pediatric cardiology market are mentioned below:

In January 2024, Occlutech received the United States Food and Drug Administration (FDA) for Occlutech Pistol Pusher and Occlutech ASD Occluder for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately commence commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc. The Occlutech ASD occluder is a nitinol, self-expanding, double-disc occlusion device that comprises two umbrella-shaped flexible discs with a waist in the middle connecting the two discs.

In February 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). The system was designed for patients suffering from RVOT anomalies who also develop severe pulmonary valve regurgitation, a condition where blood leaks into the right lower chamber of the heart after being pumped into the lungs.

In May 2022, Occlutech signed an exclusive distribution agreement with B. Braun Interventional Systems Inc (BIS). BIS will initiate the US commercialization activities for Occlutech's Flex II ASD Occluder with the support of the global Occlutech team. Through this collaboration, Occlutech records success in the strategically important US market, which is characterized as a premier and commercially attractive healthcare system. Also, BIS increases its portfolio's relevancy through strong congenital and structural heart focus.

Therefore, strategic initiatives by various companies focusing on the development of pediatric cardiology devices are likely to offer growth opportunities to the US pediatric cardiology market in the coming years.

However, the dearth of skilled pediatric cardiologists is impacting the availability and quality of care for children with cardiovascular conditions. As the incidence of congenital heart defects and other cardiac diseases continues to rise, the demand for specialized cardiology services is outpacing the supply of trained professionals. In addition, there is increasing awareness about preventive cardiology care to address long-term pediatric cardiology disorders immediately after birth. According to the American Academy of Pediatrics, there is a notable shortage of pediatric cardiologists, particularly in rural and underserved areas in the US, where access to specialized care is often limited. Based on the American Board of Pediatrics (ABP) data through June 2023, 4,117 pediatric cardiologists have ever been board-certified, of which 3,096 (75%) were actively enrolled in Maintenance of Certification (MOC). When the workforce is limited to the US, there was an average of 57.3 board-certified pediatric cardiologists per state (range 0-329) in 2023, which accounts for 4 cardiologists per 100,000 children aged to 17 years (range 0.0-25.4) across the US. There was wide variability in the distribution of pediatric cardiologists within states, with most concentrated in urban settings and few in rural areas. The shortage of pediatric cardiologists also contributes to increased pressure on existing practitioners, leading to burnout and job dissatisfaction. This situation can ultimately affect patient outcomes, as overworked specialists might not be able to provide the comprehensive care needed for complex cases. Thus, the dearth of skilled pediatric cardiologists hampers the market growth.

End User-Based Insights

Based on end users, the pediatric cardiology market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023. In the US pediatric cardiology market, the hospitals segment is significant in terms of delivering specialized care to children suffering from cardiovascular disorders. The increasing cases of congenital heart defects and other heart diseases have elevated pediatric cardiac centers with modern technologies and multidisciplinary teams for comprehensive treatment. Boston Children's Hospital, Texas Children's Hospital, Seattle Children's Hospital, and the Children's Hospital of Philadelphia are among the acknowledged leaders, boasting state-of-the-art facilities and innovative approaches to pediatric cardiology-including minimally invasive surgical techniques and interventional procedures. These hospitals emphasize collaborative care, where a cardiologist works with other surgeons, anesthesiologists, and nursing staff to ensure optimized treatment results. Seattle Children's Hospital performed ~570 pediatric heart surgeries in 2023. Recent investments in telemedicine and remote monitoring technologies further enhance patient management, with constant care and follow-up, highly necessary for patients located in rural areas. Access to specialized care and treatment protocols enhanced in health systems ensures growth in the hospitals segment and advancements in pediatric cardiology, which will improve the quality of life for young patients suffering from cardiovascular problems.

American College of Cardiology, Children's Heart Foundation, Centers for Disease Control and Prevention, United States Food and Drug Administration, and American Academy of Pediatrics are among the primary and secondary sources referred to while preparing the US pediatric cardiology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. US Pediatric Cardiology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 US Sternotomy Procedure Analysis

5. US Pediatric Cardiology Market - Key Market Dynamics

  • 5.1 US Pediatric Cardiology Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Incidence of Congenital Heart Disease in Pediatrics
    • 5.2.2 Growing Shift Toward Minimally Invasive Procedures
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Pediatric Cardiologists
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Companies
  • 5.5 Future Trends
    • 5.5.1 Integration of AI and Machine Learning with Pediatric Cardiology
  • 5.6 Impact of Drivers and Restraints:

6. US Pediatric Cardiology Market Analysis

  • 6.1 US Pediatric Cardiology Market Revenue (US$ Million), 2021-2031

7. US Pediatric Cardiology Market Analysis - by Product Type

  • 7.1 Transcatheter Heart Valves
    • 7.1.1 Overview
    • 7.1.2 Transcatheter Heart Valves: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Occlusion Devices
    • 7.2.1 Overview
    • 7.2.2 Occlusion Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Atherectomy Devices
    • 7.3.1 Overview
    • 7.3.2 Atherectomy Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Catheters
    • 7.4.1 Overview
    • 7.4.2 Catheters: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Stents
    • 7.5.1 Overview
    • 7.5.2 Stents: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Introducer Sheaths
    • 7.6.1 Overview
    • 7.6.2 Introducer Sheaths: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

8. US Pediatric Cardiology Market Analysis - by Surgical Procedures

  • 8.1 Interventional Procedures
    • 8.1.1 Overview
    • 8.1.2 Interventional Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Heart Rhythm Management Procedures
    • 8.2.1 Overview
    • 8.2.2 Heart Rhythm Management Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

9. US Pediatric Cardiology Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Specialty Clinics
    • 9.2.1 Overview
    • 9.2.2 Specialty Clinics: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

10. US Pediatric Cardiology Market Analysis - by Disease Indication

  • 10.1 Patient Foramen Ovale (PFO)
    • 10.1.1 Overview
    • 10.1.2 Patient Foramen Ovale (PFO): US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Congenital Heart Disease
    • 10.2.1 Overview
    • 10.2.2 Congenital Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Acquired Heart Disease
    • 10.3.1 Overview
    • 10.3.2 Acquired Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Arrhythmias
    • 10.4.1 Overview
    • 10.4.2 Arrhythmias: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Cardiomyopathies
    • 10.5.1 Overview
    • 10.5.2 Cardiomyopathies: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in US Pediatric Cardiology Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Edwards Lifesciences Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Terumo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 W L Gore and Associates Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 NuMED
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Cordis Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Occlutech US LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Biotronik SE & Co KG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 RENATA MEDICAL
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. US Pediatric Cardiology Market Segmentation
  • Table 2. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Product Type
  • Table 3. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Surgical Procedures
  • Table 4. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Disease Indication
  • Table 5. Recent Organic Growth Strategies in US Pediatric Cardiology Market
  • Table 6. Recent Inorganic Growth Strategies in the US Pediatric Cardiology Market
  • Table 7. Glossary of Terms, US Pediatric Cardiology Market

List Of Figures

  • Figure 1. US Pediatric Cardiology Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. US Pediatric Cardiology Market Revenue (US$ Million), 2021-2031
  • Figure 5. US Pediatric Cardiology Market Share (%) - by Product Type, 2023 and 2031
  • Figure 6. Transcatheter Heart Valves: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Occlusion Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Atherectomy Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Catheters: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Stents: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Introducer Sheaths: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. US Pediatric Cardiology Market Share (%) - by Surgical Procedures, 2023 and 2031
  • Figure 14. Interventional Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Heart Rhythm Management Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. US Pediatric Cardiology Market Share (%) - by End User, 2023 and 2031
  • Figure 18. Hospitals: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Specialty Clinics: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. US Pediatric Cardiology Market Share (%) - by Disease Indication, 2023 and 2031
  • Figure 22. Patient Foramen Ovale (PFO): US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Congenital Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Acquired Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Arrhythmias: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Cardiomyopathies: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Growth Strategies in US Pediatric Cardiology Market